Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MORF

Morphic (MORF) Stock Price, News & Analysis

Morphic logo

About Morphic Stock (NASDAQ:MORF)

Advanced Chart

Key Stats

Today's Range
$56.99
$56.99
50-Day Range
$55.74
$56.99
52-Week Range
$19.34
$57.00
Volume
400 shs
Average Volume
1.27 million shs
Market Capitalization
$2.85 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MORF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Morphic and its competitors with MarketBeat's FREE daily newsletter.

MORF Stock News Headlines

Morphic Ethical Equities Fund Limited
Eli Lilly acquires Morphic in IBD portfolio expansion
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
MORF Jan 2025 25.000 put (MORF250117P00025000)
Morphic Holding (MORF) Earnings Dates & Reports
See More Headlines

MORF Stock Analysis - Frequently Asked Questions

Morphic Holding, Inc. (NASDAQ:MORF) announced its earnings results on Thursday, July, 25th. The company reported ($1.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.96) by $0.19.

Morphic (MORF) raised $75 million in an initial public offering (IPO) on Thursday, June 27th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Jefferies, Cowen, BMO Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Morphic investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), SPDR S&P 500 ETF Trust (SPY), Advanced Micro Devices (AMD), SPDR Dow Jones Industrial Average ETF Trust (DIA), Meta Platforms (META) and Tesla (TSLA).

Company Calendar

Last Earnings
7/25/2024
Today
7/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MORF
CIK
1679363
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$152.10 million
Net Margins
N/A
Pretax Margin
-29,119.96%
Return on Equity
-26.62%
Return on Assets
-25.74%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
24.13
Quick Ratio
24.13

Sales & Book Value

Annual Sales
$520 thousand
Price / Sales
5,490.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$12.31 per share
Price / Book
4.63

Miscellaneous

Outstanding Shares
50,094,000
Free Float
37,270,000
Market Cap
$2.85 billion
Optionable
Optionable
Beta
1.49
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:MORF) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners